Effect of Telenursing on Oral Health

March 5, 2026 updated by: Sevda Ateş, Çanakkale Onsekiz Mart University

The Effect of Telenursing Interventions on Oral Health in Individuals With COPD

This research will be conducted using a pre-test and post-test control group experimental design to evaluate the effect of telenursing intervention on oral health in individuals with COPD.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Studies evaluating the effectiveness of oral health interventions in individuals with COPD are limited in the literature. Maintaining oral health is a crucial part of patient care. Sustainable nursing interventions are necessary from the onset of the disease to the end of life. Patient education conducted by nurses is important in improving medication adherence and preventing comorbidities. Furthermore, it is known that practices involving a multidisciplinary team approach with nurse participation reduce readmissions and hospital stays for COPD patients. Therefore, this study aims to evaluate the effect of telenursing intervention on oral health in individuals with COPD. The experimental group will receive oral health education via telenursing intervention (via video call) and daily oral health reminders. The control group will not receive education. Oral health education for the experimental group is planned to be given within 24 hours after the pre-test. The experimental group will be invited to the hospital one month after the oral health education for evaluation of oral health and quality of life related to oral health, and the control group will be invited one month after the pre-test.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Turkey (Türkiye)
      • Çanakkale, Turkey (Türkiye), 17100
        • Recruiting
        • Department of Nursing, Faculty of Health Sciences, Canakkale Onsekiz Mart University
        • Contact:
        • Contact:
        • Sub-Investigator:
          • SEVDA Turen, Associate Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants must have been diagnosed with COPD for at least 6 months,
  • receive inpatient treatment in internal medicine and surgical clinics,
  • signed the informed consent form to participate in the study,
  • have internet access and a mobile device with Android/iOS operating system,
  • be able to use a phone,
  • ≥ 40 years old,
  • have no communication barriers,
  • mild (Stage 1), moderate (Stage 2), severe (Stage 3), or very severe (Stage 4) stages according to the GOLD (2023) report.

Exclusion Criteria:

  • Those diagnosed with COPD less than 6 months ago,
  • Those receiving outpatient treatment,
  • Those hospitalized in the intensive care unit,
  • Those without internet access and a mobile device with Android/iOS operating system,
  • Those who do not have the ability to use a phone,
  • Those under 40 years of age,
  • Those with communication barriers,
  • Those who wish to withdraw from the research/withdraw from participation during the research process,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group
The experimental group will receive oral health education via telenursing intervention (via video call) and daily oral health reminders. Oral health education for the experimental group is planned to be given within 24 hours after the pre-test. Participants will also receive reminders regarding oral hygiene, including "performing oral care at least twice a day, every day" and "rinsing their mouths with water after using an inhaler." The experimental group will be invited to the hospital one month after the oral health education for evaluation of oral health and quality of life related to oral health.
Behavioral: telenursing
The responsible researcher will provide oral health education to the experimental group via video call during the telenursing intervention. The content of the education will include oral health in adults; the consequences of poor oral hygiene; things to pay attention to in oral health; demonstration of toothbrushing technique; and coping with care-resistant behaviors. Participants' questions regarding oral health will be answered during the call. The oral health education session is planned to last approximately 20 minutes.
Behavioral: reminders
Participants in the experimental group will be reminded to perform oral care at least twice a day, every day, and to rinse their mouths with water after using an inhaler. They will also be reminded to schedule a face-to-face meeting one month after the education.
No Intervention: control group
The control group will not receive training. They will be invited to the hospital for an oral health and quality of life check one month after the initial follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
oral healt
Time Frame: pre-test and post-test (1 month)
The Oral Assessment Guide (ADR) will be used to evaluate oral health. The guide supports the creation of an oral care protocol for patients with impaired oral mucosal membranes. Scores on the guide range from 8 to 24. According to the ADR, a low score indicates good oral health, while a high score indicates negative changes in oral health. The oral mucosal membrane score will be evaluated in both pre-test and post-test. A light source and a tongue depressor (one for each participant) are planned to be used during the oral health assessment.
pre-test and post-test (1 month)
Quality of Life Related to Oral Health
Time Frame: pre-test and post-test (1 month)
The scale has seven sub-dimensions: 'Functional Limitation', 'Physical Pain', 'Psychological Distress', 'Physical Disability', 'Psychological Disability', 'Social Disability', and 'Handicap'. Scores obtainable from the Oral Health Impact Scale range from 0 to 56. Since all questions are in a negative form, a score close to 0 indicates good quality of life related to oral and dental health, while a score close to 56 indicates poor quality of life related to oral and dental health. A high score on the scale indicates low quality of life related to oral health.
pre-test and post-test (1 month)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Çanakkale Onsekiz Mart University

Investigators

  • Principal Investigator: SEVDA ATEŞ, Associate Professor, Canakkale Onsekiz Mart University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 4, 2026

Primary Completion (Estimated)

March 4, 2026

Study Completion (Estimated)

June 30, 2026

Study Registration Dates

First Submitted

March 5, 2026

First Submitted That Met QC Criteria

March 5, 2026

First Posted (Actual)

March 10, 2026

Study Record Updates

Last Update Posted (Actual)

March 10, 2026

Last Update Submitted That Met QC Criteria

March 5, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ÇOMÜ-SBF-SA-03

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The datasets generated and/or analysed during the current study are not publicly available due privacy reasons but are available from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COPD

Clinical Trials on telenursing

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe